Influenza, Human  >>  Ampligen (rintatolimod)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ampligen (rintatolimod) / AIM ImmunoTech
NCT01591473: Safety Study of FluMist With and Without Ampligen

Terminated
1/2
55
US
Poly I:Poly C12U 50 ug, Ampligen, Rintatolimod, Poly I:Poly C12U 200 ug, Poly I:Poly C12U 500 ug, Poly I:Poly C12U 1250 ug, Placebo, FluMist
AIM ImmunoTech Inc.
Influenza, Human
09/14
08/15

Download Options